Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growth
- Purchase of UK-based Discover Momenta and Momenta Newcastle (‘Momenta’) for undisclosed amount
- Acquisition will significantly increase Liva’s reach and reflects strong synergies, as both companies provide evidence-based programmes for patients with lifestyle-related chronic conditions
- Funding secured from Nupo / IBLGroup, a new strategic investor, and existing investors
Copenhagen, Denmark, and London, UK, 5 February 2025 – Liva Healthcare (“Liva” or “the Company”), a digital health technology platform with human-led therapeutic intervention programmes that deliver best-in-class outcomes for lifestyle-related chronic diseases, today announces that it has acquired UK-based Discover Momenta, including subsidiary Momenta Newcastle, for an undisclosed sum. The acquisition of Momenta is part of Liva’s growth strategy as it emerges as a major international provider of evidence-based therapeutic lifestyle interventions.